VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30 million. The financing round was led by Revelation Partners with significant participation from the company’s existing investors, including Pacific General Ventures and EW Healthcare Partners.
Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company’s Acquisition of Medacist
Thoma Bravo, a leading software investment firm, today announced the closing of a strategic growth investment in Bluesight, the Medication Intelligence™ Company. The investment is expected to further enhance Bluesight’s drug diversion prevention offerings through its acquisition of Medacist, a pioneer in drug diversion monitoring, and continue to grow Bluesight’s inventory management and spend optimization offerings.
Revelation Partners Adds to Healthcare Investment Expertise with New Hire Rob Rein
Revelation Partners announced today that it is expanding its team with the addition of Rob Rein as Vice President at the firm. The firm, which has over $1.5 billion of capital under management, provides liquidity and flexible capital solutions to companies, investors, and general partners across all healthcare sub sectors.
Newbridge Announces Agreement For Distribution of Biogen Multiple Sclerosis Therapies in The Middle East and North Africa
NewBridge Pharmaceuticals (“NewBridge” or “the Company”) announce that they have entered a distribution agreement with Biogen International GmbH (Biogen) for the distribution and commercialization of certain Biogen Multiple Sclerosis products in selected countries in the Middle East and North Africa (“MENA”).
Vertos Medical Secures $26 Million to Expand Commercialization Efforts and Develop Breakthrough Treatments for Chronic Low Back Pain
Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced today that it has raised $26 million in an oversubscribed Series C equity funding round. The financing was led by new investor Norwest Venture Partners with participation from existing investors including Pitango Venture Capital.
Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines
Carrum Health today announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity. Revelation Partners joined the round along with return investors Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. Carrum Health will use the funding to expand its growing oncology benefit offerings and scale its surgical care service lines […]
Three Key Considerations for Healthcare Companies Raising Capital in Today’s Fundraising Environment
The healthcare industry is ever-evolving, and healthcare CEOs looking to raise money from investors in 2023 need to be well-prepared to navigate the current venture capital landscape. While overall investment in the healthcare industry was robust in 2020 and 2021, demand has cooled significantly in 2022 and so far through 2023. Investors are becoming more […]
Arcadia Raises $125 Million in New Financing from Vista Credit Partners
Arcadia (Arcadia.io), a leading data analytics platform for healthcare, today announced $125 million in financing from Vista Credit Partners, the credit-lending arm of Vista Equity Partners and a strategic investor and financing partner focused on the enterprise software, data and technology market.
Accessing Liquidity in an Illiquid Market
Presented in partnership with BDO. In this joint presentation, we discuss:
General Atlantic Leads $179M Growth Investment into Gravie
Gravie, one of the fastest growing employer health benefits companies in the United States, announced today that General Atlantic, a leading global growth equity investor, will anchor a $179 million equity investment into the Company, alongside participation from existing Gravie investors FirstMark Capital and AXA Venture Partners.